Galectin Therapeutics | 8-K: Current report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update
Galectin Therapeutics | 8-K: Current report
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update
Galectin Therapeutics | 8-K: Current report
Galectin Therapeutics | 8-K: Current report
Galectin Therapeutics | 8-K: Current report
Galectin Therapeutics | 8-K/A: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2023 and Provides Business Update
Galectin Therapeutics | DEFA14A: Others
Galectin Therapeutics | DEF 14A: Definitive information statements
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2023 and Provides Business Update
Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2023 and Provides Business Update
Galectin Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Galectin Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Galectin Therapeutics | 8-K: Current report
Galectin Therapeutics | 8-K: Current report
Galectin Therapeutics | 8-K: Current report
Galectin Therapeutics | 8-K: Current report
Galectin Therapeutics | 8-K: Current report
No Data
No Data